Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Spinal epidural lipomatosis in pediatric medulloblastoma following chemotherapy, a case report and review of the literature.

Keswa ML., Tran HN., Esfahani DR.

Case Report / Series on Back & Spine, Systemic / IV, published in Childs Nerv Syst (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Childs Nerv Syst (2025)
Country
Germany
Reported sample size
—
Source database
PubMed
PMID
39893329
DOI
10.1007/s00381-025-06757-w

Abstract (original English)

Spinal epidural lipomatosis (SEL) is a relatively rare condition characterized by overgrowth of adipose tissue in the extradural space of the spinal canal. Compression of neural structures can lead to radiculopathy, loss of sensation and motor function, and urinary retention. Known causes of SEL include exogenous steroid use and obesity. We describe the unique case of idiopathic SEL in a 1-year-old male, the youngest reported to date, diagnosed with medulloblastoma and treated with chemotherapy and autologous stem cell rescue (AuSCR). We then perform a systemic review of the literature of this rare diagnosis, explore potential causes, and review management. The patient was non-obese and received a cumulative dose of only 60 mg dexamethasone (150 mg/m 2 ), far below pediatric cancer patients with SEL documented in the literature. The acute presentation of lipomatosis following chemotherapy and AuSCR, associated with transient elevated triglycerides (234 mg/dL), suggests this as a possible cause. This case illustrates the development and resolution of SEL in a non-obese pediatric cancer patient with limited steroid use. While further study is needed to identify the etiology of SEL, this diagnosis should be evaluated for when reviewing spine imaging following chemotherapy or autologous stem cell rescue.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence
HumansMaleLipomatosisMedulloblastomaCerebellar NeoplasmsInfantEpidural SpaceDexamethasoneAntineoplastic Agents

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research